Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for Acclaim Cochlear Implant

Envoy Medical has completed the first set of activations in the final stage of its pivotal clinical study for the Acclaim cochlear implant. The study aims to evaluate the safety and efficacy of the fully implanted cochlear implant, which leverages the natural ear to capture sound. No serious adverse events were reported, and the company is pleased with the progress. Full enrollment is expected in early 2026.